Is There An Adderall Shortage 2024. Study highlights the struggle of over 15.5 million adults with adhd in accessing treatment, with medication shortages posing major challenges. In july 2024, the fda advised the dea that all manufacturers of generic vyvanse were attributing their shortages to a shortage of the active ingredient.
Rising use of adhd treatments, along with manufacturing problems, triggered an adderall shortage that first began in october 2022. Untreated adhd has significant negative.